Advertisements


Takeda CEO prescribes surgical R&D cuts after $62 billion Shire deal

LONDON (Reuters) - For Christophe Weber, the boss of Japan's Takeda Pharmaceutical , securing a $62 billion deal last week to buy drugmaker Shire at the fifth time of asking was the easy bit......»»

Category: topSource: reutersMay 17th, 2018

Takeda global ambitions grow after Shire takeover

Takeda Pharmaceutical hopes that their $62 billion deal to purchase Shire will make them a global bio-pharmaceutical leader. But as Silvia Antonioli reports, it comes with a heavy debt burden......»»

Category: videoSource: reutersMay 9th, 2018

Takeda to takeover bigger rival Shire in $62bln deal

Takeda Pharmaceutical agrees to buy London-listed Shire for 45.3 billion pounds ($61.5.....»»

Category: topSource: usatodayMay 8th, 2018

Takeda to takeover bigger rival Shire in $62bln deal

Takeda Pharmaceutical agrees to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) after the Japanese company raises the amount of cash in its offer to secure a recommendation. Silvia Antonioli reports......»»

Category: videoSource: reutersMay 8th, 2018

It"s Official: Takeda Reaches Agreement To Acquire Shire For $62 Billion

Initial reports of a pending M&A deal involving Shire PLC (ADR) (NASDAQ: SHPG) dates back to late March, when The Wall Street Journal reported that Japan-based Takeda Pharmaceuticals was interested in the Ireland-based pharmaceutical giant. read more.....»»

Category: blogSource: benzingaMay 8th, 2018

Takeda to buy pharma rival Shire in $62 billion deal

Takeda Pharmaceutical Co. on Tuesday reached an agreement to buy Shire PLC, capping a monthslong battle for control of the European drugmaker.....»»

Category: topSource: moneycentralMay 8th, 2018

Japan"s Takeda clinches $62 billion Shire deal as pharma M&A rolls on

LONDON/TOKYO (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion) on Tuesday, the biggest yet in a wave of deals sweeping the drugs industry......»»

Category: topSource: reutersMay 8th, 2018

Japan"s biggest ever deal: Takeda buys Shire for $62 billion

Japanese drugmaker Takeda has reached a $62 billion deal to buy rival Shire in the world's biggest takeover so far this year......»»

Category: topSource: cnnMay 8th, 2018

Japan"s Takeda clinches $62 billion deal to buy drugmaker Shire

LONDON/TOKYO (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to secure a recommendation......»»

Category: topSource: reutersMay 8th, 2018

Takeda Wins Battle for Shire With $62 Billion Deal

The offer from Japan’s Takeda, which values Shire at $62 billion, caps a monthslong battle for control of the European drugmaker......»»

Category: smallbizSource: wsjMay 8th, 2018

Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever

It's the largest-ever international takeover by any Japanese company, at a value of $62 billion. Japan’s Takeda Pharmaceutical is about to become.....»»

Category: europeSource: fortuneMay 8th, 2018

Takeda closes in on Shire deal with sweetened $64-billion offer

The transaction could result in a multinotch downgrade on Takeda's A1 rating, Moody's Investors Service wrote in a report on Wednesday.....»»

Category: topSource: business-standardApr 25th, 2018

Takeda Nears Shire Deal as Japanese Companies Chase Growth Overseas

Takeda is near a deal worth more than $60 billion to buy European drugmaker Shire, having raised its bid four times in a sign of how ardently Japan’s legacy companies are pursuing growth abroad as sales at home slow......»»

Category: smallbizSource: wsjApr 25th, 2018

Takeda is buying Adderall maker Shire for $64 billion in pharma"s biggest deal of the year

Reuters Takeda has reached a deal to buy Adderall drugmaker Shire for $64.3 billion.  The deal comes after a handful of rejections from Shire and a short-lived potential for a bidding war between Takeda and Botox-maker Allergan.&.....»»

Category: topSource: businessinsiderApr 25th, 2018

Shire Inches Closer to Accepting Takeda"s $64 Billion Takeover

Shire said it is willing to recommend that shareholders accept Takeda Pharmaceutical’s last-ditch $64 billion takeover bid and extended the deadline for a possible deal......»»

Category: smallbizSource: wsjApr 25th, 2018

Shire says willing to recommend Takeda"s $64 billion offer to shareholders

LONDON/NEW YORK (Reuters) - London-listed drugmaker Shire Plc said it was willing to recommend a deal with Takeda Pharmaceutical Co to its shareholders, after the Japanese company sweetened its acquisition offer to 46 billion pounds ($64 billion)......»»

Category: topSource: reutersApr 24th, 2018

Exclusive: Shire, Takeda reach breakthrough in deal talks - sources

(Reuters) - London-listed drugmaker Shire Plc and Japan's Takeda Pharmaceutical Co Ltd plan to announce a preliminary deal on Wednesday, after the latter sweetened its $62 billion acquisition offer, people familiar with the matter said......»»

Category: topSource: reutersApr 24th, 2018

The next mega merger could be a $60 billion drug deal

Shares in drug company Shire surged in London as Japan's Takeda and Allergan consider bidding......»»

Category: topSource: cnnApr 19th, 2018

Shire to Sell Oncology Unit as Takeda Mulls Takeover

Shire has agreed to sell its oncology business to French drugmaker Servier for $2.4 billion, in a deal that could discourage Takeda from launching a takeover......»»

Category: smallbizSource: wsjApr 16th, 2018

Shire to Sell Oncology Unit for $2.4 Billion as Takeda Mulls Takeover

Shire has agreed to sell its oncology business to French drugmaker Servier for $2.4 billion, in a deal that could discourage Takeda from launching a takeover......»»

Category: smallbizSource: wsjApr 16th, 2018

Takeda and Shire: A Pricey Marriage

A deal gets done, but the costs are high......»»

Category: topSource: foxnewsMay 14th, 2018